BIO names its vice chair and Am­i­cus founder John Crow­ley as next CEO

Biotech­nol­o­gy In­no­va­tion Or­ga­ni­za­tion vice chair John Crow­ley will be­come the next CEO of the in­dus­try’s ad­vo­ca­cy and lob­by­ing or­ga­ni­za­tion on March 4, pick­ing an in­sid­er from its board af­ter search­ing for more than a year.

Crow­ley, who found­ed and led Am­i­cus Ther­a­peu­tics for 17 years as CEO and chair, will re­place Rachel King, the DC-based group said Tues­day morn­ing. King has been in the BIO post on an in­ter­im ba­sis af­ter the sud­den de­par­ture of Michelle Mc­Mur­ry-Heath last Oc­to­ber.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER